Moreover, recent studies stressed importance of genetic pathway dependent on TGF-β and serum levels of IL-6, KL-6, SP-D, and CCL18 as prominent biomarkers for assessing the severity of fibrosis in SSc-related ILD. The gene discussed is TGFB1; the disease is systemic sclerosis.